LANXESS showcases extensive portfolio for the cosmetics industry at in-cosmetics Global
Highly effective preservation solutions ensuring the safety and protection of personal care products
Highly effective preservation solutions ensuring the safety and protection of personal care products
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
First and only immunotherapy to demonstrate survival benefit in this setting in a global Phase III trial
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
International Business is expected to register double-digit growth in constant currency terms
New leadership team announced at NATHEALTH Annual General Meeting 2024
Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
Subscribe To Our Newsletter & Stay Updated